Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Phase I & IIA clinical trials

27 Feb 2013 - 28 Feb 2013 - London, UK



Bookmark and Share


The Phase I & IIa Clinical Trials conference has been revamped for 2013 to provide you with two highly focused and high quality streams, providing answers to the latest questions in early phase drug development. This year we will be looking at how we can design more effective and efficient Phase I & IIa clinical trials, benchmarking against current industry models to find out what works best and how we can adapt this to our trials going forward.

6 Reasons why you MUST attend this conference……

Over 160 attendees from small, medium and large pharma and biotech companies 

Wine Casino networking event - your opportunity to meet new faces in early phase clinical development 

8 interactive sessions: Don’t miss our regulatory Q&A to get the latest updates on EU and US regulations and find out how you can remain compliant 

70 speakers including 6 Vice Presidents, 10 Heads and 15 Directors from pharma and 10 CEOs and CMOs from biotech 

Increased focus on biotech  - with speakers from 13 leading biotech companies 

2 re-engineered streams including one stream entirely dedicated to outsourcing and patient recruitment in early phase trials 

Please quote CQ4170TN when booking your place.

For more information and to download the conference brochure, please visit: 

http://www.informa-ls.com/CQ4170TN




Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models
First direct experimental proof of causal effect, researchers say.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!